Up And Down The Ladder… Job Changes

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone? And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Curis hired Ali Fattaey as president and chief operating officer. Previously, he spent eight years at Onyx Pharmaceuticals, where he was responsible for multiple programs in partnership with Pfizer and Bayer HealthCare, which led to the discovery and development of Nexavar, a drug approved to treat advanced renal cell carcinoma and unresectable hepatocellular cancer. Lundbeck will name Hakan Bjorklund as chairman; Lundbeck says Mats Pettersson is stepping down as chairman; AcelRx named Adrian Adams as chairman; Protein Sciences hired Wayne Hachey as head of gov’t & clinical affairs; Chimerix named Ernest Mario as chairman; Gyros hired Henrik Bjorkman as chief technology officer; Symphony Clinical Research hired Kate Zarish as vp, global clinical ops; BioFocus hired Peter Rehse as sr director, structural biology; Greenphire named Rory O’Hare as global product manager; Ariad Pharmaceuticals hired Jonathan Dickinson...
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized AcelRx Ariad Pharmaceuticals BioFocus Chimerix Curis Greenphire Gyros Lundbeck Protein Science Symphony Clinical Research Source Type: blogs